» Articles » PMID: 23247726

T Cells from CLL Patients Exhibit Features of T-cell Exhaustion but Retain Capacity for Cytokine Production

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2012 Dec 19
PMID 23247726
Citations 290
Authors
Affiliations
Soon will be listed here.
Abstract

T-cell exhaustion, originally described in chronic viral infections, was recently reported in solid and hematologic cancers. It is not defined whether exhaustion contributes to T-cell dysfunction observed in chronic lymphocytic leukemia (CLL). We investigated the phenotype and function of T cells from CLL patients and age-matched controls. CD8+ and CD4+ T cells from CLL patients had increased expression of exhaustion markers CD244, CD160, and PD1, with expansion of a PD1+BLIMP1HI subset. These molecules were most highly expressed in the expanded population of effector T cells in CLL. CLL CD8+ T cells showed functional defects in proliferation and cytotoxicity, with the cytolytic defect caused by impaired granzyme packaging into vesicles and nonpolarized degranulation. In contrast to virally induced exhaustion, CLL T cells showed increased production of interferon-γ and TNFα and increased expression of TBET, and normal IL2 production. These defects were not restricted to expanded populations of cytomegalovirus (CMV)–specific cells, although CMV seropositivity modulated the distribution of lymphocyte subsets, the functional defects were present irrespective of CMV serostatus. Therefore, although CLL CD8+ T cells exhibit features of T-cell exhaustion, they retain the ability to produce cytokines. These findings also exclude CMV as the sole cause of T-cell defects in CLL.

Citing Articles

Leveraging the Immunomodulatory Potential of Ibrutinib for Improved Outcomes of T Cell-Mediated Therapies of B Cell Malignancies: A Narrative Review.

Miklos D, Riedell P, Bokun A, Chavez J, Schuster S Target Oncol. 2025; .

PMID: 40035913 DOI: 10.1007/s11523-025-01133-9.


Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.

Jacobs C, Peters F, Camerini E, Cretenet G, Rietveld J, Schomakers B Cell Mol Immunol. 2025; .

PMID: 40033083 DOI: 10.1038/s41423-025-01262-1.


Normal Residual Lymphoid Cell Populations in Blood as Surrogate Biomarker of the Leukemia Cell Kinetics in CLL BinetA/Rai 0.

Solano F, Criado I, Moreno N, Gomez-Gonzalez C, Lerma-Verdejo A, Teodosio C Cancers (Basel). 2025; 17(3).

PMID: 39941719 PMC: 11815973. DOI: 10.3390/cancers17030347.


Chimeric Antigen Receptor-T Cells in the Modern Era of Chronic Lymphocytic Leukemia Treatment.

Hatashima A, Shadman M, Raghunathan V Cancers (Basel). 2025; 17(2).

PMID: 39858050 PMC: 11763375. DOI: 10.3390/cancers17020268.


Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3.

Schmitz E, Ridout A, Smith A, Eiken A, Skupa S, Drengler E Biomedicines. 2025; 12(12.

PMID: 39767763 PMC: 11673838. DOI: 10.3390/biomedicines12122857.


References
1.
Anumanthan A, Bensussan A, Boumsell L, Christ A, Blumberg R, Voss S . Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol. 1998; 161(6):2780-90. View

2.
Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth J, Sinclair A . Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002; 169(4):1984-92. DOI: 10.4049/jimmunol.169.4.1984. View

3.
Mackus W, Frakking F, Grummels A, Gamadia L, de Bree G, Hamann D . Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia. Blood. 2003; 102(3):1057-63. DOI: 10.1182/blood-2003-01-0182. View

4.
Pinon Hofbauer J, Heyder C, Denk U, Kocher T, Holler C, Trapin D . Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL. Leukemia. 2011; 25(9):1452-8. DOI: 10.1038/leu.2011.111. View

5.
Pourgheysari B, Bruton R, Parry H, Billingham L, Fegan C, Murray J . The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoire. Blood. 2010; 116(16):2968-74. DOI: 10.1182/blood-2009-12-257147. View